Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer von Howell, A., DeFriend, D.J., Blamey, R.W., Robertson, J.F., Walton, P.

Volltext

Tamoxifen withdrawal responses — chance observations or clinical clues to antioestrogen resistance? von DeFriend, D.J., Howell, A.

Volltext

86. Pharmacokinetics, systemic and antitumour effects of the specific antioestrogen ICI 182780 in women with advanced breast cancer von DeFriend, D.J., Howell, A., Robertson, J.F.R., Blamey, R.W., Anderson, L., Anderson, E., Sutcliffe, F.A., Walton, P.

Volltext

Clinical studies with the specific ‘pure’ antioestrogen ICI 182780 von Howell, A., DeFriend, D.J., Robertson, J.F.R., Blamey, R.W., Anderson, L., Anderson, E., Sutcliffe, F.A., Walton, P.

Volltext

Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer von Robertson, J.F.R., Howell, A., De Friend, D.J., Blarney, R.W., Walton, P.

Volltext